HH
Horn Howard
Chief Financial Officer
OtherM
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Horn Howard, Chief Financial Officer. Insider active across 2 companies, notably Vir Biotechnology, Inc.. Aggregated, 18 reports have been logged. Split: 0 buy · 12 sells. Total volume traded: €1.4m. History available since 17 February 2022. The latest transaction was disclosed on 3 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Horn Howard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
4,696 shares@ US$24.920.0048% mcap8.6% of flowCommon StockSEC:0001193125-26-332536:0
4,698 shares@ US$33.130.0073% mcap24.3% of flowCommon StockSEC:0001193125-26-296128:0
34,674 shares0Common StockSEC:0001193125-26-164247:0
4,683 shares@ US$20.9713.1% of flowCommon StockSEC:0001193125-26-140702:0
6,143 shares0Common StockSEC:0001193125-26-089107:0
3,061 shares@ US$23.565.6% of flowCommon StockSEC:0001193125-26-034832:0
3,150 shares@ US$22.845.7% of flowCommon StockSEC:0001193125-26-002410:0
3,081 shares@ US$36.3810.0% of flowCommon StockSEC:0001193125-25-315460:0
7,942 shares@ US$31.5125.0% of flowCommon StockSEC:0001193125-25-238708:0
1,785 shares@ US$40.4015.6% of flowCommon StockSEC:0000950170-25-036056:0
15,653 shares0Common StockSEC:0000950170-25-032750:0
7,465 shares@ US$52.7684.4% of flowCommon StockSEC:0000950170-24-114378:0
19,400 shares0Common StockSEC:0000950170-24-026672:0
80,366 shares0Common StockSEC:0001209191-23-052466:0
2,248 shares@ US$25.97330.6% of flowCommon StockSEC:0001209191-23-013007:0
2,424 shares@ US$25.28832.0% of flowCommon StockSEC:0001209191-23-011382:0
35,000 shares0Common StockSEC:0001209191-22-012951:0
2,393 shares@ US$31.930937.4% of flowCommon StockSEC:0001209191-22-011735:0
About Horn Howard
Horn Howard is Chief Financial Officer. He has 17 filings in total, and across the 17 sampled filings from 2022-02-22 to 2026-07-06, the transactions are all sales for a total of EUR 1263071, mainly in Ultragenyx Pharmaceutical Inc. and Vir Biotechnology, Inc.